BlueSeal Horizon would extend the company’s sealed-magnet design from 1.5T systems, which have been installed worldwide since 2018.


Philips has submitted its BlueSeal Horizon SI, XI, and ZI 3.0T MRI systems to the US Food and Drug Administration (FDA) for 510(k) clearance, the company announced. Philips describes BlueSeal Horizon as the first high-performance helium-free 3.0T MRI platform.

BlueSeal Horizon expands the BlueSeal helium-free portfolio to 3.0T. It also includes new features and next-generation clinical AI solutions designed to support multiple specialties, simplify workflows, and support clinical decision-making.

“The FDA submission of BlueSeal Horizon marks an important step toward bringing the benefits of helium-free 3.0T MRI to more healthcare providers and patients,” says Ioannis Panagiotelis, PhD, business leader, MR, at Philips, in a release. “As healthcare teams respond to growing demand for MRI, both innovation and resilience are critical to delivering the best care possible.”

Building on the 1.5T BlueSeal Installed Base

Philips has pursued helium-free MRI since 2018, when it introduced its BlueSeal 1.5T systems. The company reports that more than 2,500 BlueSeal 1.5T systems are installed worldwide and have saved more than 7 million liters of liquid helium to date. That figure is a calculation based on a previous-generation magnet containing 1,500 liters of helium.

For facilities teams and healthcare technology managers, Philips says the design eliminates the need for helium refills and vent pipes, and helps reduce siting complexity, installation time, and lifecycle risk. The company notes that its helium-free operation relies on 7 liters of helium permanently enclosed in the cryogenic circuit.